Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroporation | 3 | 2012 | 254 | 0.840 |
Why?
|
Adnexal Diseases | 1 | 2022 | 105 | 0.830 |
Why?
|
Magnetite Nanoparticles | 5 | 2017 | 321 | 0.800 |
Why?
|
Bile Duct Diseases | 1 | 2019 | 99 | 0.720 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2019 | 287 | 0.670 |
Why?
|
Hamartoma | 1 | 2019 | 230 | 0.650 |
Why?
|
Ovary | 1 | 2022 | 1000 | 0.640 |
Why?
|
Cysts | 1 | 2022 | 636 | 0.640 |
Why?
|
Pancreatic Cyst | 1 | 2020 | 351 | 0.620 |
Why?
|
Endosonography | 1 | 2020 | 573 | 0.610 |
Why?
|
Nipples | 1 | 2018 | 190 | 0.590 |
Why?
|
Ultrasonography, Mammary | 1 | 2018 | 252 | 0.570 |
Why?
|
Chemoembolization, Therapeutic | 2 | 2013 | 116 | 0.520 |
Why?
|
Hyperthermia, Induced | 3 | 2017 | 366 | 0.520 |
Why?
|
Gold | 2 | 2017 | 472 | 0.490 |
Why?
|
Ultrasonography | 3 | 2022 | 5922 | 0.460 |
Why?
|
Liver | 6 | 2015 | 7594 | 0.450 |
Why?
|
Pancreatic Neoplasms | 4 | 2021 | 4980 | 0.450 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 915 | 0.400 |
Why?
|
Electrochemotherapy | 1 | 2010 | 9 | 0.390 |
Why?
|
Elasticity Imaging Techniques | 1 | 2015 | 366 | 0.390 |
Why?
|
Phototherapy | 1 | 2013 | 338 | 0.390 |
Why?
|
Magnetic Resonance Imaging | 12 | 2022 | 34430 | 0.390 |
Why?
|
Neoplasms, Experimental | 2 | 2013 | 1323 | 0.370 |
Why?
|
Liver Cirrhosis | 3 | 2015 | 1757 | 0.370 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2010 | 200 | 0.350 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2011 | 2091 | 0.350 |
Why?
|
Ovarian Neoplasms | 2 | 2022 | 4751 | 0.340 |
Why?
|
Catheterization | 1 | 2012 | 1448 | 0.290 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6324 | 0.280 |
Why?
|
Cisplatin | 1 | 2012 | 1654 | 0.280 |
Why?
|
Liver Neoplasms | 3 | 2017 | 4103 | 0.260 |
Why?
|
Image Enhancement | 3 | 2013 | 2979 | 0.260 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 2939 | 0.250 |
Why?
|
Oxygen | 2 | 2011 | 4162 | 0.230 |
Why?
|
Mass Screening | 1 | 2018 | 5209 | 0.220 |
Why?
|
Neovascularization, Pathologic | 1 | 2011 | 2698 | 0.200 |
Why?
|
Embolization, Therapeutic | 3 | 2013 | 1379 | 0.180 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3494 | 0.180 |
Why?
|
Shock | 1 | 2021 | 317 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 6 | 2013 | 8545 | 0.170 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 250 | 0.170 |
Why?
|
Nanoconjugates | 1 | 2017 | 24 | 0.160 |
Why?
|
Rats | 10 | 2017 | 24860 | 0.160 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 488 | 0.160 |
Why?
|
Extremities | 1 | 2022 | 871 | 0.150 |
Why?
|
Diethylnitrosamine | 2 | 2013 | 39 | 0.150 |
Why?
|
Cell Line, Tumor | 7 | 2017 | 16736 | 0.150 |
Why?
|
Observer Variation | 1 | 2022 | 2676 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 8896 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 568 | 0.130 |
Why?
|
Incidental Findings | 1 | 2019 | 676 | 0.130 |
Why?
|
Contrast Media | 3 | 2013 | 5276 | 0.130 |
Why?
|
Infusions, Intra-Arterial | 1 | 2013 | 245 | 0.120 |
Why?
|
Ethiodized Oil | 1 | 2012 | 33 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2013 | 192 | 0.100 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14902 | 0.100 |
Why?
|
Humans | 18 | 2022 | 715777 | 0.100 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20062 | 0.100 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2556 | 0.100 |
Why?
|
Area Under Curve | 1 | 2015 | 1687 | 0.100 |
Why?
|
Models, Animal | 3 | 2012 | 2204 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2013 | 3413 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2124 | 0.090 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2013 | 648 | 0.090 |
Why?
|
Radiography | 2 | 2012 | 6978 | 0.090 |
Why?
|
Retrospective Studies | 4 | 2022 | 72443 | 0.090 |
Why?
|
Deoxycytidine | 1 | 2013 | 825 | 0.090 |
Why?
|
Photosensitizing Agents | 1 | 2013 | 610 | 0.090 |
Why?
|
Drug Carriers | 1 | 2013 | 686 | 0.090 |
Why?
|
Rabbits | 2 | 2013 | 5061 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20356 | 0.090 |
Why?
|
Antigens | 1 | 2014 | 1498 | 0.090 |
Why?
|
Female | 7 | 2022 | 377204 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2015 | 19537 | 0.080 |
Why?
|
Antigens, CD34 | 1 | 2010 | 664 | 0.080 |
Why?
|
Treatment Outcome | 6 | 2017 | 62004 | 0.080 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2010 | 385 | 0.080 |
Why?
|
Abdomen | 1 | 2013 | 1101 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2010 | 830 | 0.080 |
Why?
|
ROC Curve | 1 | 2015 | 3524 | 0.080 |
Why?
|
Ablation Techniques | 1 | 2010 | 232 | 0.080 |
Why?
|
Light | 1 | 2013 | 1434 | 0.080 |
Why?
|
Doxorubicin | 1 | 2013 | 2217 | 0.080 |
Why?
|
Hepatectomy | 1 | 2010 | 563 | 0.080 |
Why?
|
Cell Survival | 2 | 2013 | 6035 | 0.070 |
Why?
|
Animals | 13 | 2017 | 169420 | 0.070 |
Why?
|
Male | 10 | 2021 | 350324 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6736 | 0.070 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2124 | 0.070 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2170 | 0.070 |
Why?
|
Rats, Wistar | 3 | 2017 | 1980 | 0.070 |
Why?
|
Carbon Dioxide | 1 | 2010 | 1130 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4018 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2950 | 0.060 |
Why?
|
Artifacts | 1 | 2013 | 1912 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13217 | 0.060 |
Why?
|
Risk Assessment | 2 | 2022 | 23464 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2014 | 2699 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 1 | 2010 | 1016 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5397 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3687 | 0.050 |
Why?
|
Middle Aged | 3 | 2021 | 214639 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2010 | 6484 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2014 | 9004 | 0.050 |
Why?
|
Palliative Care | 1 | 2013 | 3286 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39300 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6592 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2010 | 2558 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15199 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18199 | 0.040 |
Why?
|
Adult | 2 | 2022 | 212266 | 0.040 |
Why?
|
United States | 2 | 2022 | 67905 | 0.040 |
Why?
|
Apoptosis | 1 | 2013 | 9973 | 0.040 |
Why?
|
Mucin-5B | 1 | 2017 | 137 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15909 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11689 | 0.030 |
Why?
|
Risk Factors | 1 | 2022 | 70866 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58323 | 0.030 |
Why?
|
Nanocomposites | 1 | 2015 | 56 | 0.030 |
Why?
|
Protamines | 1 | 2015 | 109 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 56226 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2010 | 13643 | 0.030 |
Why?
|
Cell Tracking | 1 | 2015 | 147 | 0.030 |
Why?
|
Cellulose | 1 | 2013 | 126 | 0.030 |
Why?
|
Ferrosoferric Oxide | 1 | 2015 | 379 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 13758 | 0.030 |
Why?
|
Dextrans | 1 | 2014 | 615 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2013 | 13626 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2012 | 6501 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2012 | 4905 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2012 | 362 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2014 | 702 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2013 | 2399 | 0.020 |
Why?
|
Hemorrhage | 1 | 2021 | 3279 | 0.020 |
Why?
|
Aged | 1 | 2020 | 162448 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2012 | 899 | 0.020 |
Why?
|
Heparin | 1 | 2015 | 1620 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2807 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3801 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 6881 | 0.020 |
Why?
|
Movement | 1 | 2013 | 1473 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3633 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6641 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2012 | 2418 | 0.020 |
Why?
|
Vaccination | 1 | 2014 | 2939 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9548 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5983 | 0.010 |
Why?
|
Mice | 2 | 2014 | 80375 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13215 | 0.010 |
Why?
|
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_